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ONE SENTENCE SUMMARY: Stimulated Raman scattering microscopy provides a 
rapid, label-free means of detecting tumor infiltration of brain tissue ex vivo and in vivo.  
 
ABSTRACT: 
Surgery is an essential component in the treatment of brain tumors. However, delineating tumor 
from normal brain remains a major challenge. Here we describe the use of stimulated Raman 
scattering (SRS) microscopy for differentiating healthy human and mouse brain tissue from 
tumor-infiltrated brain based on histoarchitectural and biochemical differences. Unlike 
traditional histopathology, SRS is a label-free technique that can be rapidly performed in situ. 
SRS microscopy was able to differentiate tumor from non-neoplastic tissue in an infiltrative  
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human glioblastoma xenograft mouse model based on their different Raman spectra. We further 
demonstrated a correlation between SRS and H&E microscopy for detection of glioma 
infiltration (κ=0.98). Finally, we applied SRS microscopy in vivo in mice during surgery to 
reveal tumor margins that were undetectable under standard operative conditions. By providing 
rapid intraoperative assessment of brain tissue, SRS microscopy may ultimately improve the 
safety and accuracy of surgeries where tumor boundaries are visually indistinct. 
 
INTRODUCTION 
The central objective in tumor surgery is to maximize tumor removal while sparing adjacent 
healthy tissue. Despite clear histologic differences, neoplastic tissue is often indistinguishable 
from healthy tissue in the operating room. Consequently, tumor is often left behind during 
surgery, leading to premature recurrence, treatment failure, and poor outcome. In addition, 
normal tissues mistaken as tumor may be removed, resulting in increased morbidity. Delineating 
normal tissue from tumor is particularly important in brain tumor surgery owing to the risk of 
neurologic deficit associated with damaging functional cerebral structures.  Moreover, given the 
technical complexity of removing brain tumors that infiltrate into normal brain such as 
glioblastoma multiforme (GBM), as well as less infiltrative tumors such as metastases and 
meningiomas, defining an optimal surgical endpoint has been a long-standing challenge in the 
field of neurosurgical oncology (1-4). Extent of resection is a key prognostic factor for brain 
tumor patients (5-8) and the prevalence of suboptimal surgical results is surprisingly high in 
current neurosurgical practice (9). Consequently, tools designed to safely maximize the removal 
of neoplastic tissue are critically important (10).  
Coherent Raman scattering microscopies, including coherent anti-Stokes Raman 
scattering (CARS) (11, 12) and stimulated Raman scattering (SRS) microscopy (13-16), are 
emerging techniques for imaging biological tissues based on the intrinsic vibrational 
spectroscopy of their molecular components such as lipids, proteins, and DNA (17-21). Label- 
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free imaging techniques are gaining acceptance within the medical imaging field because they 
are free from the drawbacks of dye-based methods, including heterogeneous delivery and non-
specific staining (22). In comparison to other label-free techniques, such as two-photon 
fluorescence, second harmonic generation, and third harmonic generation (23, 24), coherent 
Raman microscopy has high chemical selectivity, enabling its use in complex biological 
applications including brain imaging (18, 20, 25, 26). CARS and SRS have enhanced sensitivity 
over conventional spontaneous Raman scattering owing to the coherent nature of signal 
generation, enabling high-speed, real-time imaging in reflectance or epi mode (27, 28). 
Moreover, the intrinsic 3D optical sectioning capability of nonlinear optical microscopy is well-
suited for intraoperative imaging, eliminating the need for thin tissue sectioning to create a 
microscopic image (11, 28, 29). 
SRS has several advantages over CARS for biomedical imaging, including a linear 
relationship between signal intensity and chemical concentration, as well as a non-distorted 
spectrum almost identical to that of spontaneous Raman, enabling quantitative chemical imaging 
(13, 17). Furthermore, by adding spectroscopic information, multi-color SRS microscopy enables 
the differentiation of normal and tumor-infiltrated tissues based on biochemical and 
morphological properties (20). In this study, we show that two-color SRS microscopy can be 
used to detect glioma ex vivo in human GBM xenograft mice, with results that correlated with 
the interpretation of hematoxylin and eosin (H&E)–stained slides by a surgical pathologist.  Most 
importantly, we demonstrate that SRS microscopy can detect tumor margins in vivo in regions 
that appear grossly normal under standard bright field conditions. By enabling intraoperative 
microscopic, label-free imaging, SRS holds promise for improving the accuracy and 
effectiveness of cancer surgery.   
4 
 
 
RESULTS 
SRS microscopy of mouse brain tissue 
Stimulated Raman scattering (Fig. 1A) microscopy enables the visualization of tissue 
architecture based on the intrinsic Raman spectra of macromolecules (proteins, lipids, etc.). 
Differences in Raman spectra among brain regions reflect different compositions of these 
macromolecules. Figure 1B shows the Raman spectra in different regions of brain including 
lipid-rich white matter, lipid- and protein-rich cortex, and protein-rich tumor in human brain 
tumor xenografts in mice. The ratio of Raman signals at 2930 cm
-1 and 2845 cm
-1 (S2930/S2845) 
reflects the different lipid and protein contents. Densely cellular or solid tumor regions in mice 
had a mean intensity ratio of S2930/S2845 = 4.0 ± 0.3, whereas cortex and white matter had mean 
ratios of 1.6 ± 0.1 and 0.93 ± 0.04 (±SEM, n=8), respectively. We verified that the SRS signals 
predominantly came from the lipid and protein contents by demonstrating that Raman spectra of 
different brain regions (i.e., white matter, cortex and tumor) can be fit to linear combinations of 
lipid and protein spectra (fig. S1).  
The microscope setup and the design of epi-detector for SRS imaging at reflection (epi) 
mode are shown in Fig. 1C, and explained in detail in the Materials and Methods. In images 
taken at 2845 cm
-1 (pump at 816.7 nm), nuclei and cell bodies appeared darker than surrounding 
extracellular structures because of the lack of lipid (Fig. 1D). In contrast, the difference in 
intensity between cellular and extracellular structures in images obtained at 2930 cm
-1 (pump at 
811.2 nm) was much more subtle (Fig. 1D). We used a linear combination method to extract the 
lipid and protein distributions (17, 20) from the two-channel images and color-coded them as 
green and blue, respectively (Fig. 1D). This two-color SRS imaging method mapped the proper  
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distribution of cell bodies as well as extracellular structures, providing the structural and 
chemical contrast for microscopic tissue imaging. 
  We began by evaluating the ability of SRS microscopy to image the tissue architecture of 
the normal mouse brain. Thin (10 µm), unstained, snap-frozen sections were imaged non-
destructively with SRS and subsequently stained with H&E and imaged with light microscopy 
for comparison (Fig. 2). A tiling approach was successful in collecting individual overlapping 
regions of interest that could be reconstructed to create a composite image of the entire imaged 
slice (Fig. 2A). Imaging identical sections of normal mouse brains with both SRS and H&E 
demonstrated the ability of SRS microscopy to detect characteristic large-scale histoarchitectural 
features, such as the hallmark “jellyroll” pattern of cellular layers of the hippocampus (Fig. 2B). 
SRS microscopy also clearly differentiated smaller-scale structural features of the brain, such as 
the interface between the cerebral cortex and subcortical white matter, as well as the cornus 
ammonis 1 (CA1) region of the hippocampus (Fig. 2C).  SRS was particularly well-suited for 
differentiating cortex from subcortical white matter at the gray/white junction owing to the 
strong 2845 cm
-1 signal measured in white matter (Fig. 2D). In general, highly cellular regions 
within the hippocampus had high signal intensity at 2930 cm
-1 (Fig. 2C, arrow), whereas the 
extracellular compartment in the brain, including white matter tracts, tended to have high signal 
intensity at 2845 cm
-1 (Fig. 2C, asterisk). Consequently, densely cellular regions appeared blue, 
while tightly packed white matter tracts appeared green.  The cortex is composed of blue cells 
organized in a laminar fashion within a background of faintly green extracellular matrix, 
containing both proteins and lipid (Fig. 2C, dagger).  
Unlike H&E, where contrast is generated by the binding of eosin and hematoxylin to a 
range of intracellular and extracellular molecules, contrast in SRS microscopic images is related  
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to the SRS signal intensities at 2930 cm
-1 and 2845 cm
-1.  The basis of contrast in SRS 
microscopy explains why it is well-suited for differentiating cellular regions which have high 
S2930 and low S2845, from acellular, myelin-rich regions such as fiber tracts which have both high 
S2930 and S2845. However, both SRS microscopy and H&E staining are capable of generating 
similar images of the microscopic architecture of tissues with tight cell-to-cell correlation (Fig. 
2D, circles). 
 
Detecting and classifying tumor-infiltrated mouse brain via SRS microscopy   
The diagnosis of high-grade gliomas, such as GBM, relies on the presence of specific histologic 
features (dense cellularity, mitoses, microvascular proliferation and/or necrosis) that are not 
present in normal brain (30). After verifying that SRS microscopy accurately captured the 
microscopic architecture of normal structures within the murine brain (Fig. 2), we evaluated 
whether it could also detect distinct histo-architectural patterns seen in human GBM xenografts 
in mice. Through detailed spectroscopic measurements in the C-H stretching region, we 
established that Raman spectra differed substantially between tumor-infiltrated brain tissue and 
adjacent, non-infiltrated gray and white matter (Fig. 1B). Such spectral signatures, together with 
structural differences, provided the contrast between tumor-infiltrated and normal tissues.  
  Coronal brain sections of human GBM xenografts were imaged with both SRS and H&E 
microscopy for comparison (Fig. 3A). Tumor-infiltrated brain tissue was easily differentiated 
from the surrounding healthy tissue with SRS microscopy based on differences in cellular 
density (Fig. 3, B to D), the presence of infiltration within white matter bundles [tumor-
infiltrated bundle (Fig. 3C, arrowhead); normal white matter bundle (Fig. 3C, asterisk)], and the 
replacement of the relatively acellular-appearing matrix of the cortex by tumor cells (Fig. 3, B  
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and D). In many instances, SRS microscopy was capable of identifying infiltrating tumor even at 
low tumor density, when 25-75% of the field was considered infiltrated by tumor cells (Fig. 3C 
and fig. S2). SRS microscopy was also effective for differentiating regions of tissue with little or 
no tumor infiltration, where < 25% of the field was infiltrated by tumor cells (Fig. 3B), and 
dense tumor infiltration involving >75% of the field of view (Fig. 3D).  
To quantitatively evaluate SRS as a diagnostic method for identifying tumor infiltration 
in specific regions of interest, we compared tumor detection via SRS and corresponding H&E 
microscopic images obtained from three full coronal sections of mice with orthotopic human 
GBM xenografts and three full coronal sections from normal mouse brains.  The full SRS and 
H&E microscopic images were used to generate 75 350 x 350 µm
2 fields of view (FOV), 
representing 25 FOV from each of three categories: normal to minimally hypercellular tissue 
with scattered atypical cells (Fig. 3B), infiltrating glioma (Fig. 3C), and high-density glioma. A 
web-based survey was populated with all 150 images (75 H&E, 75 SRS) and presented in 
random order. Each of the 150 FOVs (75 SRS and 75 H&E FOV) was classified by three 
neuropathologists (SS, SCP, KL), yielding a total of 450 observations. Pathologists were asked 
to categorize the FOVs into one of the following categories: normal to minimally hypercellular 
tissue with scattered atypical cells (normal), or infiltrating to high-density glioma (tumor). 
Results of the survey are detailed in Table 1 and table S1. Rating of H&E FOVs by 
neuropathologists was correct for all FOVs. There were 2 errors in classification of the SRS 
images, both in subtle distinctions: one misclassification of a FOV defined as normal to 
minimally hypercellular tissue with scattered atypical cells as infiltrating to high-density glioma; 
one misclassification of infiltrating glioma as normal to minimally hypercellular tissue with 
scattered atypical cells (table S1).  The κ coefficient comparing the two modalities was 0.98  
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(95% CI, 0.95 - 0.99), demonstrating very good concordance (31) between H&E and SRS with 
respect to tumor detection.  
 
Ex vivo epi-SRS microscopy in fresh mouse brain sections 
Imaging of thick, fresh tissue specimens and of tissues in situ requires reflectance or back-
scattering SRS imaging. We have previously demonstrated the feasibility of SRS imaging based 
on back-scattered signal (epi-mode) (28), rather than signal transmitted through the specimen 
(transmission mode). To evaluate the imaging of fresh tissue, we performed epi-SRS microscopy 
on freshly sectioned 2-mm-thick mouse brain slices from normal mice. A comparison between 
transmission and epi-SRS shows similarity between the two imaging modes (fig. S3), which 
confirms the theoretical equivalence of transmission and epi-SRS imaging. Minor differences in 
the images might originate from heterogeneous light transmission and scattering across the 
tissue.  
We focused on regions within the central nervous system that have a distinct histologic 
appearance and demonstrated that epi-SRS microscopy on fresh tissue sections generates images 
free of the artifacts associated with freezing and fixation. A comparison of Fig. 4A and Fig. 2A 
demonstrate differences in the imaging of fresh and frozen sections. In the frozen section there 
are inconsistencies in the tissue that result in a splotchy, blue appearance throughout the SRS 
image as well as staining inconsistencies, related to artifacts of tissue processing (fig. S4). By 
eliminating the artifacts inherent in imaging frozen or fixed tissues, the histoarchitecture of the 
fresh mouse brain was captured with improved clarity. The expected 6-layer pattern of the 
cerebral cortex (Fig. 4B) and the jellyroll pattern of the hippocampus (Fig. 4C) were captured in 
a manner that clearly depicts cellular and acellular regions. SRS imaging of white matter  
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revealed tightly packed fiber tracts (Fig. 4D). The choroid plexus demonstrated the expected 
pattern of cuboidal epithelium surrounding vascular cores (Fig. 4E). In the hippocampus and 
dentate gyrus (Fig. 4C), SRS imaging depicted densely arcs of cells appearing blue surrounded 
by a hypocellular matrix of brain parenchyma appearing greenish. SRS imaging of hypothalamic 
nuclei (Fig. 4F) and habenular nucleus (Fig. 4G) reveal more evenly spaced cellular regions that 
bordering midline ventricular boundaries. Moderately sized tracts traversing the caudatoputamen 
showed the ability of SRS imaging to differentiate white and gray matter (Fig. 4H).   
         We further investigated the use of SRS microscopy on freshly excised tumor tissue from 
an infiltrative GBM xenograft model (BT112) known to recapitulate many of the histologic 
features of human GBM (32). Using the color assignment described in Fig. 1D, the densely 
cellular tumor core appeared uniformly blue in comparison to the largely green appearance of 
surrounding hypocellular or acellular normal brain (Fig. 4I). From a structural perspective, brain 
tumors are characterized as hypercellular lesions, which may both displace adjacent tissues 
(mass effect) and infiltrate into normal gray and white matter. The blue appearance of the core of 
the GBM xenografts suggests hypercellularity and replacement of the greenish appearance of 
normal brain parenchyma, and provides a basis for distinguishing the boundaries of the tumor 
from the non-infiltrated regions of the normal brain (Fig. 4I). Under high magnification, tumor 
cells were readily apparent owing to their high nuclear-to-cytoplasmic ratio, dense growth 
pattern, and anaplasia (Fig. 4J).   
Diffuse infiltration by small clusters of infiltrating tumor cells into brain parenchyma at 
the apparent margins of the tumor/gray matter interface can be readily distinguished (Fig. 4K, 
white dashed line). Where tumor has grown into the white matter, densely cellular, blue regions 
of infiltrating tumor cells dispersed throughout the green fiber tracts that are normally tightly  
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arranged (Fig. 4L). Sampling of contiguous regions of interest from minimally infiltrated brain 
through the apparent tumor margin and into the tumor core (Fig. 4K, red dashed line) 
demonstrated a trend towards higher S2930/S2845 with increasing tumor density (Fig. 4M). SRS 
images of fresh brain slices from other GBM cell lines and non-GBM mice models are also 
shown (fig. S5) to demonstrate the applicability of our method to other experimental human 
tumor models. 
 
In vivo epi-SRS brain tumor microscopy 
To determine whether SRS microscopy was feasible in vivo, we used an infiltrative human GBM 
xenograft mouse model to recapitulate the irregular, diffuse border of human gliomas. In six 
mice, we generated human GBM xenografts that grew to the cortical surface. Craniectomies 
exposed the tumor engraftment site as well as adjacent non-invaded brain tissue, so that we could 
apply a coverslip to create a “cranial window” for the SRS imaging system. The cortical surface 
was imaged through a cranial window. SRS image acquisition used a total laser power of ~150 
mW, which could in principle be reduced (fig. S6).  
The pattern of arachnoidal and pial vessels on the surface of the normal brain was clearly 
identifiable in both the standard bright field and SRS images (Fig. 5A). The movement of 
individual blood cells through vessels captured in the SRS images results in a blurred appearance 
within the vessel lumina. Differences in the vascular patterns between the images are related to 
vessels existing superficial to the thin optical sectioning plane captured by SRS imaging. There 
was no gross evidence of tumor on the surface of the brain using standard bright field 
microscopy (Fig. 5A, left). Interestingly, however, some regions of brain tissue that appeared 
grossly normal under bright field microscopy demonstrated extensive tumor infiltration on SRS  
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microscopy (Fig. 5A and fig. S7). As expected from ex vivo imaging, infiltrating tumor margins 
were readily visible when SRS microscopy was performed in vivo. The tumor margin (Fig. 5A, 
dashed line) was discernable both from a biochemical and structural perspective, with GBM 
xenograft tissue appearing blue and cellular (Fig. 5, B and C).  
Within non-infiltrated (normal) brain tissue, normal axonal processes and the vascular 
pattern characteristic of non-infiltrated cortex were visible (Fig. 5D; movie S1; fig. S7). The 
features of both tumor-infiltrated and non-infiltrated cortex varied with image depth. A 100-µm 
depth-stack, acquired from superficial to deep, near a tumor-brain interface demonstrated a 
transition from hypercellular, blue tumor superficially to hypocellular green cortex with 
intermixed linear structures, most likely representing astrocytic processes in the deeper portion 
of the sample (movie S1). 
Differences in tumor infiltration seen during SRS imaging were also confirmed by H&E 
histology following in vivo imaging (fig. S8). The H&E-stained sections were acquired from a 
coronal plane perpendicular to the imaging planes in Fig. 5. In the H&E images, basophilic 
hypercellular tumor tissue can be seen originating in the cortex, extending upward to cover the 
surface of the hemisphere, and downward toward the corpus callosum (fig. S8). Although tissue 
movements caused by the respiratory and cardiac cycles resulted in a slight degradation in image 
quality in comparison to ex vivo SRS imaging, we were still able to identify individual cells, at 
the tumor/brain interface (Fig. 5C). We hypothesize that the individual cells are likely neoplastic 
given the paucity of cells at this imaging depth in normal cortex.  
We also confirmed that similar histoarchitectural features could be appreciated in 
simulated surgical conditions (Fig. 6). Prior to dissection, the surface of the brain appears 
acellular with frequent subarachnoid and pial vessels (Fig. 6A).  Deep (approximately 1 mm)  
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dissection was then carried out in the surgical field to simulate the manipulation of tissues that 
occurs during human brain tumor resection. Under these simulated surgical conditions, we were 
able to appreciate the interface between tumor and normal brain (Fig. 6B), as well as the normal-
appearing white matter and cortical architecture that would be seen following tumor resection 
(Fig. 6C).   
 
Ex vivo imaging of fresh human brain tumor specimens 
To test the hypothesis that SRS microscopy could detect differences between tumor-infiltrated 
and non-infiltrated human brain, we imaged several fresh specimens removed during the course 
of a recurrent glioblastoma resection. The portions of the tissue removed from the patient were 
mounted on slides, entirely unprocessed and imaged with transmission SRS microscopy. SRS 
images corresponded well with similar regions imaged by traditional H&E histology (Fig. 7). As 
in human glioblastoma xenografts, glioblastoma–infiltrated human brain demonstrated 
hypercellularity (Fig. 7A) compared to non- or minimally-infiltrated areas (Fig. 7B). In addition, 
key diagnostic features were present in the human surgical specimens, including cellular and 
nuclear pleomorphism (Fig. 7C), pseudopallisading necrosis (Fig. 7D), and microvascular 
proliferation (Fig. 7E).   
 
DISCUSSION 
Here we provide the first evidence that SRS microscopy can be used to delineate tumor tissue in 
a human GBM xenograft mouse model, both ex vivo and in vivo, and in human brain tumor 
surgical specimens.  Importantly, because it is possible to perform SRS microscopy and H&E 
microscopy on the same tissue sections, we were able to define the relationship between SRS and  
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H&E microscopic images. SRS microscopy depicted much of the histologic information 
conveyed by H&E microscopy without the need for thin sectioning or tissue staining. SRS also 
provided biochemical distinction between normal and tumor-infiltrated tissues by highlighting 
differences in the S2930/S2845 ratio. SRS images demonstrating densely arranged cells and a high 
S2930/S2845 ratio are suggestive of regions with extensive tumor infiltration on H&E. In contrast, 
SRS images demonstrating normal cerebral histoarchitectural features (regularly spaced multi-
layered neuronal cell bodies, glial components of white matter, axonal and astrocytic processes, 
and white matter bundles) and a low S2930/S2845 ratio are suggestive of non-infiltrated tissues on 
H&E microscopy.  
  Although SRS microscopy does not reveal all of the architectural, genetic, and 
biochemical data that can be gleaned from thin section analysis, it is well-suited for 
differentiating normal brain from regions infiltrated by tumor based on structural features and 
S2930/S2845 ratiometry. Alternative Raman bands might be used to delineate tumor from normal 
brain as well. For example, we have recently demonstrated that the Raman band at 1080 cm
-1 
could serve as a marker for nucleic acids to image cell nuclei with high specificity (21).  
However, its relatively weak Raman intensity has hindered the 1080 cm
-1 band from being a 
favorable probe in in vivo applications. In contrast, the C-H stretching region including 2930 cm
-
1 and 2845 cm
-1 bands are among the strongest Raman bands in biological specimens, providing 
sufficient signal/noise ratio for high-speed SRS imaging. Ideally, a strong tumor-specific Raman 
band based on one or more chemical species that are unique to tumor cells would provide the 
best means for delineating normal and tumor-infiltrated regions. However, given inter- and 
intratumoral biochemical variability and the limited Raman spectral differences between normal 
and tumor cells, it is unlikely that such a band exists.  
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  In our study, SRS microscopy performed well for detecting human GBM tumor 
infiltration in mice, especially in densely tumor-infiltrated FOVs. Classification of tumor 
infiltration status of FOV in this study was based primarily on disruption of normal 
histoarchitectural motifs, such as cortical layers and white matter bundles, as well as an 
assessment of cellular density. Whether H&E or SRS is used, it is difficult to definitively classify 
a given cell as neoplastic or non-neoplastic based on morphology alone. Nonetheless, by 
enabling classification of tissue through histoarchitectural criteria, SRS creates the possibility of 
rapid delineation of tumor-infiltrated tissues. If applied to the surgical setting, SRS could be used 
to redefine surgical endpoints based on microarchitectural data rather than the notoriously 
unreliable gross visual and textural cues that are widely employed by surgeons today (8, 9, 33).  
         SRS offers major advantages over clinically available (and several experimental) dye-based 
strategies conceived to distinguish normal brain from tumor-infiltrated tissues. Dye-based 
strategies rely on the extravasation of intravenously administered dyes into a tumor (6, 34). 
However, the inhomogeneous nature of dye distribution within tumors has been appreciated for 
decades (22). Moreover, normal nervous tissues and some neoplastic tissues (ie, low grade 
glioma) possessing an intact blood-brain barrier take up little circulating dye and are difficult to 
image. By probing molecular species that exist in both tumor-infiltrated and non-infiltrated 
tissues in different concentrations, SRS is not reliant on the delivery of dye for tumor 
delineation.  Consequently, unlike dye-based methods for tumor delineation, SRS microscopy is 
uniquely well-suited for imaging normal, non-tumor-infiltrated tissues that should be avoided to 
minimize surgical morbidity.  
Given the fact that glioma cells are known to infiltrate up to four centimeters from the 
tumor core (35), the goal of glioma surgery is maximal cytoreduction of the mass lesion rather  
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than the removal of all infiltrating tumor cells.  However, safely resectable residual tumor is 
unintentionally left in the operative cavity in the vast majority of glioblastoma surgeries (10).  
Although the imaging depth of SRS microscopy is limited to 100 µm, it provides a potential 
means of rapidly defining areas of residual tumor on the surface of a resection cavity during 
surgeries (Fig. 6). Furthermore, we anticipate that SRS microscopy would be used in an iterative 
fashion throughout surgery, much in the way intraoperative handheld microscopy is being 
currently evaluated as a method for evaluating the cellularity of the leading edge of dissection in 
glioma surgery (36). To evaluate the histoarchitecture of tissues beyond the resection cavity with 
handheld microscopy, further dissection to expose the tissues of interest is required.  We 
anticipate that the same imaging protocol would be required when handheld SRS microscopy is 
deployed. 
Several engineering challenges including motion correction and the development of 
protocols for efficient sampling of a surgical cavity, will be necessary prior to clinical 
translation. Current image-guidance systems are invaluable for operative planning. However, 
their navigational accuracy declines as tissues shift during surgery (37). By providing rapid, 
actionable imaging data from within the operative field, a handheld intraoperative SRS imaging 
system would enable histology-based image-guidance that is immune to navigational errors. 
Reductions in the average laser pulse power needed to generate SRS images are also possible by 
optimizing the laser pulse properties, such as pulse duration and repetition rate, improving the 
likelihood that SRS microscopy will be safe for use in the human brain (fig. S6).  
A rigorous evaluation of the performance of SRS microscopy in human brain tumor 
specimens will be required to accurately judge the feasibility of clinical translation. Nonetheless, 
here we provide the first ex vivo human data to demonstrate the feasibility of distinguishing  
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glioblastoma-infiltrated brain from non-invaded tissue here (Fig. 7). The ability to extrapolate the 
performance of SRS microscopy in true surgical conditions based on in vivo imaging in a mouse 
cranial window model is limited.  Among the barriers to intraoperative imaging are the presence 
of blood within the surgical cavity, the effects of mechanical tissue manipulation by surgical 
dissection and motion artifacts. The clinical translation of SRS microscopy will also require the 
development of a handheld surgical device that can be used to acquire images from within a 
surgical cavity.  
Extent of resection has emerged as one of the most important prognostic factors for many 
tumors.  Yet, the goal of maximizing extent of resection is inconsistently achieved. The studies 
in mouse models of human GBM presented here suggest that SRS microscopy holds great 
potential for discriminating tumor tissue from non-tumor-infiltrated tissue and may ultimately be 
used to optimize the surgical treatment of cancer.  
 
MATERIALS and METHODS 
Study design  
 The central goal of this study was to evaluate the ability of SRS microscopy to image brain 
tumor infiltration. We began by comparing thin frozen section SRS imaging with standard H/E 
histopathology in normal mice (n=6) and human glioblastoma xenograft models (n=6). We then 
quantified the correlation between SRS and H/E tissue imaging through a web-based survey 
administered to neuropathologists, who were blinded to the tumor infiltration status of the fields 
of view (n=75) they were grading. Next, we evaluated SRS imaging of fresh tissues in normal 
mince (n=10) and human glioblastoma mouse models (n=6), first ex vivo, then in vivo. Finally, 
we utilized an amendment to the brain tumor bank protocol at the Brigham and Women’s  
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Hospital to procure tissue to evaluate the ability of SRS to image tumor infiltration in human 
surgical specimens (n=1).  
 
Imaging system 
The principles and setup of the SRS microscope have been previously described in detail (13, 
28). Briefly, we used a Stokes beam at 1064 nm (picoTRAIN, High Q Laser; 7 ps, 76 MHz), and 
a tunable pump beam (650 – 1000 nm) from an optical parametric oscillator (Levante Emerald, 
APE GmbH). The two pulse trains were then spatially and temporally overlapped, aligned into a 
laser scanning microscope (FV300; Olympus), and focused into the sample. The energy 
difference between the pump and Stokes photons was tuned to match the energy of a specific 
molecular vibration to induce a stimulated Raman scattering process, resulting in excitation of 
the ground state (ν=0) molecules to their vibrational excited state (ν=1) (Fig. 1A). The intensity 
loss of the pump beam is the so-called stimulated Raman loss (SRL), and the intensity gain of the 
Stokes beam is the so-called stimulated Raman gain (SRG). All SRS images in this work were 
acquired from SRL, whose spectra have been shown to replicate that of spontaneous Raman 
scattering (13, 28). In order to detect the small fraction of SRL signal over the large pump 
intensity (ΔI/I < 10
-4), we modulated the Stokes beam at a high frequency (10 MHz) using an 
electro-optical modulator (EOM), and detected the SRL signal by a home-built lock-in amplifier 
with a time constant of ~1 µs (Fig. 1C). We used the fastest imaging speed of the microscope (1 
second/frame) for both ex vivo and in vivo experiments. 
  A specially designed epi-detector was invented by Saar et al. (28) to detect the back-
scattered signal from thick (> 1 mm) tissues and live targets. Modifications to this design are 
described in Supplementary Methods.   
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GBM cell line and xenografts 
The GBM cell line BT112 was derived from surgical resection material acquired from 
glioblastoma patients undergoing neurosurgery at the Brigham and Women’s Hospital on a 
protocol approved by their Institutional Review Board.  Briefly, tumor fragments were 
mechanically dissociated using the MACS Brain Tumor Dissociation Kit (Miltenyi Biotech) and 
tumorspheres were established according to the manufacturer’s protocol (38).  Tumorspheres 
were propagated in human NeuroCult NS-A Proliferation Media (StemCell Technologies) 
supplemented with EGF, FGFb (Miltenyi Biotech), and heparin sulfate (StemCell 
Technologies).  BT112 xenografts were generated by injecting 100,000 cells in the right striatum 
or superficial cortex of SCID mice (IcrTac:ICR-Prkdcscid; Charles River Labs) and aged under 
standard conditions. 
 
Fresh mouse tissue preparation 
Mice were anesthetized with isoflurane and decapitated. Brains were harvested from freshly 
sacrificed mice, rinsed with normal saline, and placed in a brain mold. Sections were sliced at 2-
mm intervals manually with a razor blade and placed on a microscope slide between two 
coverslips.  
 
Fresh human brain tumor specimen imaging 
Human tissue was procured from a patient undergoing brain tumor resection at the Brigham and 
Women’s Hospital through Partners IRB protocol (#2011P002387). The Partners IRB protocol 
(#2011 P002387) supports the collection and research utilization of brain tumor tissue collected  
19 
 
from all eligible patients at the Brigham and Women’s Hospital and Dana Farber Cancer 
Institute. The patient (n = 1) was informed of the risks of participating in the study during the 
consent process. A portion of the tissue, in excess of what was needed for histopathologic 
diagnosis, was allocated for SRS imaging during surgery. Tissue was then transferred to the 
imaging laboratory, stored in cold saline, placed on a glass slide, and imaged in transmission 
mode, as described above in the Imaging system section. 
 
Statistical analysis 
Statistical analysis comparing concordance between H&E and SRS was performed using the 
kappa statistic and its two-sided 95% confidence interval, based on the asymptotic variance of 
the kappa statistic (whose validity is supported by the study’s sample size) and the standard 
normal distribution (39). Analyses were performed using SAS software version 9.2 (SAS 
Institute Inc.). We assessed the concordance of SRS and H&E microscopy to classify the 75 
identical FOVs as being consistent with normal to minimally hypercellular tissue with scattered 
atypical cells, or infiltrating or dense glioma. The κ statistic is calculated as a measure of 
agreement between the two methods, with values of < 0.40 indicating poor to slight agreement, 
0.41 – 0.60 fair to moderate, 0.61 – 0.80 good, and 0.81 – 1.00 very good agreement (40). No 
multiplicity adjustments were made to the nominal significance level for testing. 
 
SUPPLEMENTARY MATERIALS 
 
Supplementary Methods 
Fig. S1. Raman spectra of brain tissue, lipids and proteins. 
Fig. S2. Representative infiltrating glioma SRS FOVs correctly classified by neuropathologists.  
20 
 
Fig. S3. Comparison between transmission and epi-SRS images.  
Fig. S4. Comparison of SRS images in fresh and frozen tissues. 
Fig. S5. SRS images of various mouse models of human brain tumors. 
Fig. S6. Power scaling of SRS microscopy. 
Fig. S7. Additional in vivo SRS images of GBM xenografts. 
Fig. S8. Coronal H&E staining after in vivo imaging. 
Table S1. Compiled contingency table summarizing survey results. 
Movie S1. Three-dimensional depth profile of brain tumor margin. 
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FIGURE LEGENDS 
Figure 1. Two-color SRS microscopy. (A) Energy diagram of the SRS process, where pump 
and Stokes photons excite the ground state (ν=0) molecules to their vibrational excited state 
(ν=1), resulting in the reduction of pump intensity–stimulated Raman loss (SRL) and the 
increase in Stokes intensity–stimulated Raman gain (SRG). (B) Raman spectra from frozen 
sections of a mouse brain with human GBM xenografts show white matter, cortex, and tumor. 
The marked frequencies at 2845 cm
-1 and 2930 cm
-1 were chosen for two-color SRS imaging. 
(C) Experimental setup of epi-SRS microscopy. Stokes beam was modulated at high frequency 
(10 MHz), and the weak SRL signal was demodulated by a lock-in amplifier. Epi-detection 
scheme was used for in vivo brain imaging and ex vivo imaging on fresh tissues. CS, coverslip; 
DC, dichroic mirror; EOM, electro-optical modulator; FI, optical filter; PD, photodiode; SL, 
saline. (D) Neurons in gray matter were imaged at 2845 cm
-1 (left) and 2930 cm
-1 (middle). A 
linear combination of the two raw images was used to compute the distributions of lipid (green) 
and protein (blue), shown in a composite image (right).  
 
Figure 2. SRS and H&E images of frozen normal mouse brain sections. Images are 
representative of 6 mice. Images were taken with SRS microscopy, and then stained with H&E 
for comparison. Lipids have been false-colored green; proteins in blue. (A) A full coronal section  
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of normal mouse brain. (B) SRS microscopy demonstrates major structural features of the 
normal brain, such as the hippocampus shown here. (C) SRS microscopy differentiates regions 
of the brain based primarily on cellularity and the relative presence of lipids and proteins. Cortex 
(dagger), white matter (asterisk), and the CA1 region of the hippocampus (arrow) are readily 
identified. (D) The gray/white junction is evident owing to the differences in lipid concentration 
between cortical and subcortical tissue, with cell-to-cell correlation between SRS and H&E 
images (circles).   
 
Figure 3. SRS and H&E images of frozen human GBM xenografts. Images are representative 
of 6 mice. Images were taken with SRS microscopy, and then stained with H&E for comparison.  
Lipids have been assigned to the green channel and proteins to the blue channel. (A) A thin (10 
µm), full section of snap-frozen brain from implanted human GBM xenograft in mice. (B) High-
magnification view of normal to minimally hypercellular cortex. (C) Infiltrating glioma with 
normal white matter bundles (asterisk), tumor-infiltrated bundles (arrow), and dense tumor cells 
(arrowhead). (D) High-density glioma. FOVs similar to these were used to populate the Web-
based survey to quantitatively compare SRS and H&E microscopy.  
 
Figure  4.  Epi-SRS  images  of  fresh  brain  slices  from  normal  mouse  and  human  GBM 
xenograft (BT112) mouse model . Images are representative of 10 normal mice (A to H)  and 6 
BT112 mice (I to M). Lipids have been assigned to the green channel and proteins to the blue 
channel. Fresh 2-mm thick coronal section of normal mouse brain. Structural features of the full 
section from a normal mouse (A), cortex (B), hippocampus (C), corpus callosum (D), choroid 
plexus  (E),  hypothalamic  nuclei  (F),  habenular  nucleus  (G),  and  caudatoputamen  (H) 
demonstrate  the  expected  histoloarchitectural  patterns.  In  contrast,  fresh  2-mm-thick  coronal 
brain section of a BT112 human glioblastoma xenograft-bearing mouse reveals normal, green 
appearing brain parenchyma surrounding blue hypercellular tumor (I). High magnification of the 
tumor core reveals individual tumor cells (J). The tumor-gray matter interface (white dashed line) 
demonstrates  an  invasive  pattern  of  tumor  growth  (K).  The  tumor-white  matter  interface, 
demonstrates  the  ability  of  tumor  cells  (blue)  to  traverse  and  separate  white  matter  bundles 
(green) (L). A line profile of S2930/S2845 across the gray matter/tumor interface in (K, red dot-
dashed line) shows higher S2930/S2845 with increasing tumor density (M). 
 
Figure  5.  In  vivo  SRS  microscopy  images  of  human  GBM  xenografts.  Images  are 
representative of 6 mice. SRS imaging was carried out via acute cranial window preparation in 
mice 24 days post-implantation of human GBM xenografts. (A) Bright field microscopy appears 
grossly  normal,  whereas  SRS  microscopy  within  the  same  FOV  demonstrates  distinctions 
between tumor-infiltrated areas and non-infiltrated brain (normal), with a normal brain/tumor 
interface  (dashed  line).  (B  to  D)  High-magnification  views  within  the  tumor  (B),  at  the 
tumor/brain interface (C), and within normal brain (D).  
 
 
Figure 6. SRS imaging during simulated tumor resection on mouse brain. En face, epi-SRS 
images were obtained in vivo during various stages of a simulated tumor removal. The cartoons  
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on the right show the depth of imaging. In a tumor located beneath the cortical surface, there is 
no obvious abnormality in SRS (left) or brightfield images (middle) when imaging the cortical 
surface (A). After a portion of the cortex has been removed, the tumor is revealed. Blood was 
present  on  the  dissected  surface,  but  did  not  adversely  affect  the  distinction  from  tumor-
infiltrated  regions  from  non-infiltrated  regions  (B).  As  dissection  was  carried  deep  past  the 
tumor, the normal appearance of white matter and cortex was again visible (C).  
 
 
Figure 7. SRS and H&E microscopy of freshly excised tissue from a human brain tumor. 
SRS images were obtain from freshly excised human glioblastoma specimen and compared to 
similar regions in H/E stained tissue from the same specimen. The hypercellularity of viable 
tumor (A) contrasts with normocellular regions of adjacent brain with with minimal tumor 
infiltration (B). Higher magnification images of the different regions in the specimen 
demonstrate key diagnostic features of glioblastoma including cellular pleomorphism (C), 
pseudopallisading necrosis, where densely cellular regions (arrow) border bland, acellular 
regions of necrosis (asterisk) (D); and microvascular proliferation (E). 
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Table 1.  Quantitative comparison of H&E histology and SRS microscopy. Three 
neuropathologists (R1, R2, and R3) reviewed a series of 75 H&E-stained tissues and 75 
corresponding SRS images and recorded their diagnoses via Web-based survey.  The category 
indicated as “normal” in the table represents FOVs categorized as normal to minimally 
hypercellular tissue with scattered atypical cells.  
 
Diagnosis 
  R1  R2  R3  Overall 
accuracy 
(%)    Correct  Incorrect  Correct  Incorrect  Correct  Incorrect 
Normal 
H&E  25  0  25  0  25  0  100 
SRS  24  1  25  0  25  0  98.7 
Infiltrating  
glioma 
H&E  25  0  25  0  25  0  100 
SRS  25  0  24  1  25  0  98.7 
High-density  
glioma 
H&E  25  0  25  0  25  0  100 
SRS  25  0  25  0  25  0  100 
TOTAL    149  1  149  1  150  0  99.5 
 
 
 
  
27 
 
 
Fig.1  
 
 
 
 
 
 
  
28 
 
 
Fig. 2 
 
 
 
 
  
29 
 
 
Fig. 3 
 
 
  
30 
 
 
Fig. 4 
 
 
 
  
31 
 
 
Fig. 5 
 
 
 
 
  
32 
 
 
Fig. 6 
 
 
 
  
33 
 
 
Fig. 7 
 
 
 
 